Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	52	non-cytoplasmic
53	74	transmembrane
75	81	cytoplasmic
82	101	transmembrane
102	106	non-cytoplasmic
107	132	transmembrane
133	151	cytoplasmic
152	170	transmembrane
171	200	non-cytoplasmic
201	220	transmembrane
221	245	cytoplasmic
246	268	transmembrane
269	286	non-cytoplasmic
287	307	transmembrane
308	315	cytoplasmic
316	335	transmembrane
336	340	non-cytoplasmic
341	362	transmembrane
363	372	cytoplasmic
373	393	transmembrane
394	412	non-cytoplasmic
413	433	transmembrane
434	448	cytoplasmic

Input:
>WP_010526643.1 NCBI__GCF_000220155.1:WP_010526643.1
METKSKVVEKQHLVSFILITSLFFLWGIANDLTNPMVSAFKKVMPELSNFEAALVQLAFY
GGYATMAIPAALFVRKYSYKKGILLGLLLYATGALLFYPAAAYEKFGFFLASLYVLTFGL
AFLETVSNPFILSMGAKETATRRLNLSQTFNPPGSLLGMLLAQLFVINLLQSDDYTPAQY
NALSASEQAAIRSNDLSVISWPYIGLGCLVLVMFILIAVAKMPKLKEEAHLPVGQSFRVL
MKNKRYYFGVIAQAFYVGAQIMCWTFIFQYVDNLNASRPADAQLTATWYNMAAMVAFLTG
RALSTYLLKYIGPGKLMMYFALGAIGLTLGTIFIIDMGGLYCLVGISVMMSLMFPTIYGI
ALKDMGEEAKLGSAGLVMAIVGGALLPPLQGLILDLGGEGFSDVLLFGYIPEVNFSFVLP
MVSFIVVAVYSYYSHKYYLKDDYLMSKS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server